Picture of Lipidor AB logo

LIPI — Lipidor AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Lipidor AB Licence Agreement Grants Menarini Group, Relife Srl,Exclusive Rights To Register, Promote, Distribute,Market 2New Psoriasis Drug Candidates

July 2 (Reuters) - Lipidor AB  LIPI.ST :
    * LIPIDOR AB LICENCE AGREEMENT GRANTS MENARINI GROUP, RELIFE
SRL,EXCLUSIVE RIGHTS TO REGISTER, PROMOTE, DISTRIBUTE,MARKET
2NEW PSORIASIS DRUG CANDIDATES
    * LIPIDOR AB - TOTAL POTENTIAL VALUE OF THIS AGREEMENT IS UP
TO
MEUR 70
    * LIPIDOR AB- WILL BE ELIGIBLE TO RECEIVE MILESTONE PAYMENTS
OF UP
TO MEUR 19 AND A VOLUME-BASED ROYALTY PLAN LEADING UP TO TEENS
DIGIT VALUES ON SALES 
    * LIPIDOR AB  LIPI.ST  - RESULTS FROM PHASE III STUDY OF
THIS
SECOND CANDIDATE, CURRENTLY IN ITS INITIAL STAGES, ARE EXPECTED
FOR FIRST HALF OF 2022 
    * LIPIDOR AB  LIPI.ST  - LIPIDOR'S PARTNER AURENA
LABORATORIES
WILL BE RESPONSIBLE FOR COMMERCIAL PRODUCTION OF PRODUCTS 

Source text for Eikon:  ID:nWkr4RssbY 
Further company coverage:  LIPI.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lipidor AB

See all news